Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Detecting and quantifying stress granules in tissues of multicellular organisms with the Obj.MPP analysis tool.

De Graeve F, Debreuve E, Rahmoun S, Ecsedi S, Bahri A, Hubstenberger A, Descombes X, Besse F.

Traffic. 2019 Sep;20(9):697-711. doi: 10.1111/tra.12678. Epub 2019 Aug 6.

PMID:
31314165
2.

The methylome of the celiac intestinal epithelium harbours genotype-independent alterations in the HLA region.

Fernandez-Jimenez N, Garcia-Etxebarria K, Plaza-Izurieta L, Romero-Garmendia I, Jauregi-Miguel A, Legarda M, Ecsedi S, Castellanos-Rubio A, Cahais V, Cuenin C, Degli Esposti D, Irastorza I, Hernandez-Vargas H, Herceg Z, Bilbao JR.

Sci Rep. 2019 Feb 4;9(1):1298. doi: 10.1038/s41598-018-37746-6.

3.

Detection of CCND1 Locus Amplification by Fluorescence In Situ Hybridization.

Balázs M, Koroknai V, Szász I, Ecsedi S.

Methods Mol Biol. 2018;1726:85-100. doi: 10.1007/978-1-4939-7565-5_9.

PMID:
29468546
4.

Lowly methylated region analysis identifies EBF1 as a potential epigenetic modifier in breast cancer.

Fernandez-Jimenez N, Sklias A, Ecsedi S, Cahais V, Degli-Esposti D, Jay A, Ancey PB, Woo HD, Hernandez-Vargas H, Herceg Z.

Epigenetics. 2017;12(11):964-972. doi: 10.1080/15592294.2017.1373919. Epub 2017 Nov 10.

5.

TET-Catalyzed 5-Hydroxymethylation Precedes HNF4A Promoter Choice during Differentiation of Bipotent Liver Progenitors.

Ancey PB, Ecsedi S, Lambert MP, Talukdar FR, Cros MP, Glaise D, Narvaez DM, Chauvet V, Herceg Z, Corlu A, Hernandez-Vargas H.

Stem Cell Reports. 2017 Jul 11;9(1):264-278. doi: 10.1016/j.stemcr.2017.05.023. Epub 2017 Jun 22.

6.

Unique DNA methylation signature in HPV-positive head and neck squamous cell carcinomas.

Degli Esposti D, Sklias A, Lima SC, Beghelli-de la Forest Divonne S, Cahais V, Fernandez-Jimenez N, Cros MP, Ecsedi S, Cuenin C, Bouaoun L, Byrnes G, Accardi R, Sudaka A, Giordanengo V, Hernandez-Vargas H, Pinto LF, Van Obberghen-Schilling E, Herceg Z.

Genome Med. 2017 Apr 5;9(1):33. doi: 10.1186/s13073-017-0419-z.

7.

Altered integrin expression patterns shown by microarray in human cutaneous melanoma.

Vizkeleti L, Kiss T, Koroknai V, Ecsedi S, Papp O, Szasz I, Adany R, Balazs M.

Melanoma Res. 2017 Jun;27(3):180-188. doi: 10.1097/CMR.0000000000000322.

PMID:
28234767
8.

[Melanoma research in Hungary: promising results in a previously orphan tumor].

Balázs M, Vízkeleti L, Ecsedi S, Ádány R, Rásó E, Hegedûs B, Ladányi A, Tóvári J, Tímár J.

Magy Onkol. 2015 Dec;59(4):275-81. Epub 2015 Oct 25. Hungarian.

9.

Genomic profiling of invasive melanoma cell lines by array comparative genomic hybridization.

Koroknai V, Ecsedi S, Vízkeleti L, Kiss T, Szász I, Lukács A, Papp O, Ádány R, Balázs M.

Melanoma Res. 2016 Apr;26(2):100-7. doi: 10.1097/CMR.0000000000000227.

PMID:
26656572
10.

The role of osteopontin expression in melanoma progression.

Kiss T, Ecsedi S, Vizkeleti L, Koroknai V, Emri G, Kovács N, Adany R, Balazs M.

Tumour Biol. 2015 Sep;36(10):7841-7. doi: 10.1007/s13277-015-3495-y. Epub 2015 May 7.

PMID:
25944164
11.

DNA methylation characteristics of primary melanomas with distinct biological behaviour.

Ecsedi S, Hernandez-Vargas H, Lima SC, Vizkeleti L, Toth R, Lazar V, Koroknai V, Kiss T, Emri G, Herceg Z, Adany R, Balazs M.

PLoS One. 2014 May 15;9(5):e96612. doi: 10.1371/journal.pone.0096612. eCollection 2014.

12.

Transposable hypomethylation is associated with metastatic capacity of primary melanomas.

Ecsedi SI, Hernandez-Vargas H, Lima SC, Herceg Z, Adany R, Balazs M.

Int J Clin Exp Pathol. 2013 Nov 15;6(12):2943-8. eCollection 2013.

13.

Integrative genomics identifies gene signature associated with melanoma ulceration.

Rakosy Z, Ecsedi S, Toth R, Vizkeleti L, Hernandez-Vargas H, Lazar V, Emri G, Szatmari I, Herceg Z, Adany R, Balazs M.

PLoS One. 2013;8(1):e54958. doi: 10.1371/journal.pone.0054958. Epub 2013 Jan 30. Erratum in: PLoS One. 2013;8(4). doi:10.1371/annotation/27b2c2c3-3b09-4c0c-9e20-8dc0226404f3. Herandez-Vargas, Hector [corrected to Hernandez-Vargas, Hector].

14.

Array CGH analysis of the rare laryngeal basaloid squamous cell carcinoma: a case report.

Ecsedi S, Tóth L, Balázs M.

Int J Clin Exp Pathol. 2012;5(8):834-9. Epub 2012 Oct 1.

15.

The role of CCND1 alterations during the progression of cutaneous malignant melanoma.

Vízkeleti L, Ecsedi S, Rákosy Z, Orosz A, Lázár V, Emri G, Koroknai V, Kiss T, Ádány R, Balázs M.

Tumour Biol. 2012 Dec;33(6):2189-99. doi: 10.1007/s13277-012-0480-6. Epub 2012 Sep 23.

PMID:
23001925
16.

Marked genetic differences between BRAF and NRAS mutated primary melanomas as revealed by array comparative genomic hybridization.

Lázár V, Ecsedi S, Vízkeleti L, Rákosy Z, Boross G, Szappanos B, Bégány A, Emri G, Adány R, Balázs M.

Melanoma Res. 2012 Jun;22(3):202-14. doi: 10.1097/CMR.0b013e328352dbc8.

PMID:
22456166
17.

Prognostic relevance of the expressions of CAV1 and TES genes on 7q31 in melanoma.

Vizkeleti L, Ecsedi S, Rakosy Z, Begany A, Emri G, Toth R, Orosz A, Szollosi AG, Mehes G, Adany R, Balazs M.

Front Biosci (Elite Ed). 2012 Jan 1;4:1802-12.

PMID:
22201996
18.

Characterization of candidate gene copy number alterations in the 11q13 region along with BRAF and NRAS mutations in human melanoma.

Lázár V, Ecsedi S, Szöllosi AG, Tóth R, Vízkeleti L, Rákosy Z, Bégány A, Adány R, Balázs M.

Mod Pathol. 2009 Oct;22(10):1367-78. doi: 10.1038/modpathol.2009.109. Epub 2009 Jul 24.

19.

Elevated level of tenascin and matrix metalloproteinase 9 correlates with the bone destruction capacity of cholesteatomas.

Juhász A, Sziklai I, Rákosy Z, Ecsedi S, Adány R, Balázs M.

Otol Neurotol. 2009 Jun;30(4):559-65. doi: 10.1097/MAO.0b013e31819fe6ed.

PMID:
19395987
20.

Chromosomal imbalances are associated with increased proliferation and might contribute to bone destruction in cholesteatoma.

Ecsedi S, Rákosy Z, Vízkeleti L, Juhász A, Sziklai I, Adány R, Balázs M.

Otolaryngol Head Neck Surg. 2008 Nov;139(5):635-40. doi: 10.1016/j.otohns.2008.07.019.

PMID:
18984256
21.

Characterization of 9p21 copy number alterations in human melanoma by fluorescence in situ hybridization.

Rákosy Z, Vízkeleti L, Ecsedi S, Bégány A, Emri G, Adány R, Balázs M.

Cancer Genet Cytogenet. 2008 Apr 15;182(2):116-21. doi: 10.1016/j.cancergencyto.2008.01.008.

PMID:
18406873
22.

EGFR gene copy number alterations in primary cutaneous malignant melanomas are associated with poor prognosis.

Rákosy Z, Vízkeleti L, Ecsedi S, Vokó Z, Bégány A, Barok M, Krekk Z, Gallai M, Szentirmay Z, Adány R, Balázs M.

Int J Cancer. 2007 Oct 15;121(8):1729-37.

Supplemental Content

Loading ...
Support Center